The 2026 Musculoskeletal New Ventures Conference (MNVC) begins Day 1 in Memphis, Tennessee, bringing together entrepreneurs, surgeons, investors, and medical technology leaders to explore innovation across the orthopedic and spine industries.
Taking place October 27–28 at the FedEx Institute of Technology, MNVC provides a platform for emerging companies to present their technologies, connect with industry professionals, and explore opportunities for investment and collaboration.
Today’s agenda features presentations from a diverse group of innovative companies, including SutureTech, SteriCUBE, Tetrous, and 1OR Health, to name just a few. These companies are showcasing advancements in medical technology, from surgical repair and regenerative medicine to operating room readiness, offering attendees valuable insights into emerging solutions addressing challenges in musculoskeletal healthcare.
MNVC 2026 Day 1: Company Presentations
The first day features company presentations throughout the morning and afternoon, alongside networking opportunities and discussions about the business environment for private medical technology companies.
SutureTech | 9:40 AM
SutureTech presents at 9:40 AM, with founder and CEO Oke Anakwenze, MD, MBA, representing the company.
The company focuses on simplifying tendon and ligament repair through medical device technology. Its work addresses soft tissue-to-bone repair, an important area of orthopedic surgery, particularly in sports medicine procedures.
At MNVC, attendees can learn more about SutureTech’s approach to surgical repair and hear directly from its leadership. The presentation provides an opportunity to explore how medical device companies are developing solutions for specific clinical challenges.
SteriCUBE | 10:30 AM
SteriCUBE takes the stage at 10:30 AM, with CEO Chris Whitmore representing the company.
The presentation continues the morning’s lineup of businesses participating in the musculoskeletal innovation ecosystem. Company sessions give attendees an opportunity to discover emerging organizations, hear their leaders explain their work, and identify potential areas for further discussion.
SteriCUBE’s inclusion adds another perspective to the day’s program, which brings together companies and professionals interested in developments across medical technology and healthcare.
Tetrous | 11:30 AM
Tetrous is scheduled for 11:30 AM, with Chairman and CEO Bradley E. Patt representing the company.
Tetrous focuses on regenerative medicine technologies for enthesis repair. The enthesis is the area where a tendon or ligament attaches to bone, making it an important consideration in orthopedic procedures.
The company’s work includes sports medicine applications involving the tendon-to-bone interface. Addressing this area presents specific challenges because successful repair depends on the healing of tissues at the attachment site.
The presentation gives attendees an opportunity to learn about Tetrous’s approach and its place within the evolving field of musculoskeletal innovation.
1OR Health | 1:40 PM
The afternoon program features 1OR Health at 1:40 PM, with founder and CEO Jesse Moralez listed as the presenter. The company is scheduled in the Methodist Presentation Theatre.
1OR Health focuses on surgical case readiness, helping teams track requirements, coordinate responsibilities, and identify unresolved issues before patients enter the operating room.
Surgical preparation involves multiple people, processes, and essential details. When requirements remain incomplete, healthcare teams may face delays and scheduling disruptions. Technology that improves visibility into outstanding tasks can help teams coordinate their work more effectively.
The presentation introduces an operational perspective to the conference, demonstrating how digital solutions can support surgical preparation and healthcare workflows.
Beyond Presentations: Networking and Industry Insights
MNVC brings together professionals from across the orthopedic and spine industries to discuss innovation, investment, and business development. Company presentations are central to the event, but networking and industry discussions also create opportunities for valuable connections.
Day 1 includes networking breaks, a discussion about financing and mergers and acquisitions for private companies, and a strategic roundtable featuring industry leaders.
These sessions address important considerations for emerging medical technology businesses. Entrepreneurs can connect with investors and potential partners, while industry executives can discover companies and explore opportunities for collaboration.
For investors, the event provides exposure to businesses working across the musculoskeletal sector. For founders, it creates opportunities to introduce their technologies, communicate their goals, and develop relationships that may support future growth.
By bringing these groups together, MNVC encourages conversations that connect innovation with the commercial and strategic realities of the medical technology industry.
Why MNVC Matters for Musculoskeletal Innovation
Musculoskeletal healthcare includes orthopedic devices, spine technologies, surgical systems, and regenerative medicine. Progress across these fields depends on collaboration among clinicians, researchers, entrepreneurs, investors, and established medical technology organizations.
Events such as MNVC create opportunities for these groups to exchange perspectives, discover emerging technologies, and discuss clinical and operational challenges.
For presenting companies, the conference offers a platform to introduce their work to an audience with relevant industry experience. Attendees can learn about company leadership, explore different approaches to healthcare challenges, and build relationships beyond individual presentations.
This combination of technology showcases and industry engagement makes MNVC an important meeting point for professionals interested in the future of orthopedic and spine care.
Explore the MNVC 2026 Agenda and Presenters
The 2026 Musculoskeletal New Ventures Conference continues in Memphis with company presentations, industry discussions, and networking opportunities.
Visit the official MNVC website for conference information, review the MNVC 2026 agenda for presentation times and session details, and explore the 2026 presenters and speakers to learn more about the leaders participating in this year’s event.
As Day 1 unfolds, innovative companies such as SutureTech, SteriCUBE, Tetrous, and 1OR Health are among those sharing insights and showcasing advancements in medical technology, surgical innovation, and the future of musculoskeletal healthcare.